Fidelity Investments’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$421M Sell
16,947,888
-42,866
-0.3% -$1.11M 0.02% 575
2025
Q4
$432M Buy
16,990,754
+2,261,199
+15% +$50.4M 0.02% 566
2025
Q3
$237M Sell
14,729,555
-3,869,640
-21% -$62.6M 0.01% 772
2025
Q2
$298M Buy
18,599,195
+1,358,160
+8% +$20.5M 0.02% 668
2025
Q1
$295M Buy
17,241,035
+4,143,120
+32% +$86.7M 0.02% 660
2024
Q4
$324M Buy
13,097,915
+560,344
+4% +$15.9M 0.02% 632
2024
Q3
$357M Buy
12,537,571
+2,053,688
+20% +$60.6M 0.02% 599
2024
Q2
$277M Buy
10,483,883
+2,827,938
+37% +$80.4M 0.02% 663
2024
Q1
$247M Sell
7,655,945
-219,877
-3% -$8.02M 0.02% 714
2023
Q4
$332M Buy
7,875,822
+127,276
+2% +$4.68M 0.03% 559
2023
Q3
$297M Buy
7,748,546
+2,494,678
+47% +$56.4M 0.03% 561
2023
Q2
$99.7M Buy
5,253,868
+1,106,899
+27% +$20.6M 0.01% 994
2023
Q1
$64.3M Buy
4,146,969
+1,658,836
+67% +$28.8M 0.01% 1157
2022
Q4
$44.2M Buy
2,488,133
+2,487,410
+344,040% +$31.3M ﹤0.01% 1302
2022
Q3
$4K Buy
723
+23
+3% +$112 ﹤0.01% 4391
2022
Q2
$3K Sell
700
-193
-22% -$834 ﹤0.01% 4460
2022
Q1
$5K Buy
+893
New +$5.56K ﹤0.01% 4437
2020
Q4
Sell
-200,000
Closed -$7.04M 4071
2020
Q3
$7.04M Buy
+200,000
New +$6.02M ﹤0.01% 1949

Other funds holding IMVT